EDGAR Filing Documents for 0001209191-15-055571

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-15-055571

Filing Date

2015-06-23

Accepted

2015-06-23 10:29:21

Documents

Period of Report

2015-06-22

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	10275
	Complete submission text file	0001209191-15-055571.txt		11818

Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421

Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900

SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 37 HANCOCK STREET BOSTON MA 02114

Business Address

WIRTH PETER (Reporting) CIK: 0001021041 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 15946284
SIC: 2836 Biological Products, (No Diagnostic Substances)